The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The South Korea medical tourism market is expected to exhibit a CAGR of XX% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Medical tourism refers to a planned excursion across international borders to avail certain medical treatments. These treatments range from cosmetic, ophthalmic, dental, cardiovascular, and orthopedic services to various complex procedures, such as stem-cell transplants. Some of the common considerations undertaken while selecting the location include treatment costs, the availability of skilled medical personnel and advanced healthcare facilities, distance, etc. Besides enhancing the quality of life, medical tourism offers numerous economic benefits, including generating healthcare jobs, setting global healthcare standards, exchanging knowledge, increasing foreign revenues, etc.
The growing inbound medical travel owing to the availability of state-of-the-art healthcare facilities, highly-trained practitioners, and cost-effective treatments is primarily driving the South Korea medical tourism market. Besides this, the increasing adoption of elective medical procedures that are not covered by medical insurance, such as fertility treatments, gender reassignment surgeries, reproductive therapy, dental reconstruction, cosmetic surgeries, etc., is acting as another significant growth-inducing factor. Furthermore, several initiatives undertaken by the government of South Korea to create awareness and promote medical tourism are also catalyzing the market growth. For instance, the Ministry of Health and Welfare (MOHW) improved the safety of international patients by introducing mandatory registration of medical institutions serving foreign patients and compulsory medical malpractice liability insurance. Additionally, numerous healthcare organizations and centers are also offering comprehensive medical tourism packages to patients, which include all travel-related services ranging from ticket bookings to accommodation and healthcare coverage. This, in turn, is creating a positive outlook for the market. Apart from this, the emerging trend of combining wellness practices with traditional Korean medicinal therapies is expected to drive the growth of the South Korea medical tourism market in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the South Korea medical tourism market report, along with forecasts for the period 2022-2027. Our report has categorized the market based on type and treatment type.
Breakup by Type:
Breakup by Treatment Type:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ajou University Medical Center, Banobagi Plastic Surgery, CHA Fertility Center, Injeuniversity Haeundae Hospital, JK Plastic Surgery Center, Keimyung University Dongsan Hospital, Korea Medical Hub, Nasaret International Hospital, Sun Medical Center and Wonkwang University Hospital.
|Base Year of the Analysis||2021|
|Segment Coverage||Type, Treatment Type|
|Companies Covered||Ajou University Medical Center, Banobagi Plastic Surgery, CHA Fertility Center, Injeuniversity Haeundae Hospital, JK Plastic Surgery Center, Keimyung University Dongsan Hospital, Korea Medical Hub, Nasaret International Hospital, Sun Medical Center and Wonkwang University Hospital.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at